7TM Pharma, Rotterdam
AT1 -Mas complex could be target for intervention in CV diseases
Published in Cardiovascular Device Liability Week, June 12th, 2005
According to scientists in Netherlands, "We previously identified the G-protein-coupled receptor Mas, encoded by the Mas proto-oncogene, as an endogenous receptor for the heptapeptide angiotensin-(1-7); however, the receptor is also suggested to be involved in actions of angiotensin II. We therefore tested whether this could be mediated indirectly through an interaction with the angiotensin II type 1 receptor, AT1 ."
E. Kostenis and colleagues of 7TM Pharma explained, "In transfected mammalian cells, Mas was not activated by angiotensin...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Cedars-Sinai Medical Center
Abnormal heart scans predict higher risks for African Americans, Hispanics - Kaiser Permanente
Abdominal obesity predicts declining insulin sensitivity - MicroVention, Inc.
Medical device company awarded patent for embolization device - Stanford University
Bioethicists want stronger protections for women donating eggs for study - U.S. Department of Energy
MEF2A mutations are not a common cause of coronary artery disease - Aarhus University Hospital
Procollagen propeptide examined, relationship to strain in hypertension shown - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
